2
F e d e r a t i o n o f A m e r i c a n S o c i e t i e s f o r E x p e r i m e n t a l B i o l o g y Annual Report 2006[ ]
Q u a l i t y L i f e T h r o u g h R e s e a r c h
Ta b l e o f C o n t e n t s
FASEB Member Societies ......................................................2
FASEB Board ..........................................................................2
President’s Report ..................................................................3
Executive Director's Report ....................................................5
FASEB Public Affairs ..............................................................8
Collaborative Efforts ............................................................12
FASEB Committees ..............................................................14
The FASEB Journal ..............................................................24
FASEB Departments ............................................................26
FASEB Clients ......................................................................26
Financial Report ..................................................................27
Member Societies of the Federation ....................................32
[ ]
F e d e r a t i o n o f A m e r i c a n S o c i e t i e s f o r E x p e r i m e n t a l B i o l o g y
M i s s i o n S t a t e m e n t
The Federation of American Societies for Experimental
Biology (FASEB) advances biological science through
collaborative advocacy for research policies that promote
scientific progress and education and lead to improve-
ments in human health.
[ ]
Q u a l i t y L i f e T h r o u g h R e s e a r c h
F A S E B
FASEB MEMBER SOCIETIES
The American Physiological Society – APS
American Society for Biochemistry and Molecular
Biology – ASBMB
American Society for Pharmacology and
Experimental Therapeutics – ASPET
American Society for Investigative Pathology – ASIP
American Society for Nutrition – ASN
The American Association of Immunologists – AAI
American Association of Anatomists – AAA
The Protein Society
Society for Developmental Biology – SDB
American Peptide Society – APepS
Association of Biomolecular Resource
Facilities – ABRF
The American Society for Bone and Mineral
Research – ASBMR
American Society for Clinical Investigation – ASCI
Society for the Study of Reproduction – SSR
Teratology Society
The Endocrine Society – TES
The American Society of Human Genetics – ASHG
Society for Gynecologic Investigation – SGI
Environmental Mutagen Society – EMS
International Society for Computational
Biology – ISCB
American College of Sports Medicine – ACSM
FASEB BOARD
Officers
President – Leo T. Furcht
President-Elect – Robert E. Palazzo
Past President – Bruce R. Bistrian
Vice President for Science Policy – John A. Smith
Treasurer – Kenneth G. Mann
Secretary – Guy C. Fogleman
Directors
Richard B. Marchase (Past VP for Science Policy)
D. Neil Granger (APS)
Judith S. Bond (ASBMB)
David B. Bylund (ASPET)
Peter A.Ward (ASIP)
Dennis M. Bier (ASN)
Fred D. Finkelman (AAI)
Mark O. Lively (ABRF) (VP-Elect for Science Policy)
Kathryn J. Jones (AAA)
Gerald L. Hazelbauer (Protein)
Peter H. Mathers (SDB)
Fred R. Naider (APepS)
Paula H. Stern (ASBMR)
Gregory G. Germino (ASCI)
Virendra B. Mahesh (SSR)
John M. DeSesso (Teratology)
Henry M. Kronenberg (TES)
Loraine A. Oman-Ganes (ASHG)
James C. Rose (SGI)
Jeffrey L. Schwartz (EMS)
Barbara Bryant (ISCB)
Carl Foster (ACSM)
Advisors
Heidi E. Hamm (ASBMB)
James E. Barrett (ASPET)
David H. Baker (ASN)
Mark R. Boothby (AAI)
Joseph C. LaManna (AAA)
Richard A. Houghten (APepS)
Jay W. Fox (ABRF)
Asgerally T. Fazleabas (SSR)
Linda C. Giudice (SGI)
Michael Gribskov (ISCB)
[ ]
All information reported as of December 31,2006
2
“”
... we persevered, meetingwith congressional staffand continuing to pressour positions, and towardsthe end of the year—in an incredible flurry of activity—our persistencepaid off.
This year it has been my privilege to be a part of a very dynam-
ic organization that is making a major impact on policies
affecting biomedical science. FASEB plays a critical role in
advocacy for researchers, and I would like to highlight a few of
our major accomplishments of 2006.
When I took office in July, I was able to build upon the efforts
started by my predecessor, Bruce Bistrian. Under his steward-
ship, FASEB energetically supported the efforts of moderates in
Congress to raise the funding level for health and research spending in the FY 2007 budget.
FASEB also strongly supported competitiveness initiatives that proposed substantial funding
increases for NSF and DOE. While the struggle would be long and the outcome uncertain
for many months, this effort proved critical in the final stages of the appropriations process.
In May and June, scientists from our Member Societies contacted their Representatives and
successfully encouraged the House to pass the Stem Cell Research Enhancement Act. The
Senate passed the stem cell bill in July and the issue of stem cell research became an
important election issue propelling many new pro-science candidates into office.
Then, with lengthy recesses for holidays and elections, many observers felt major legislation
pertaining to research would never even come to a vote. But we persevered, meeting with
congressional staff and continuing to press our positions, and towards the end of the
year—in an incredible flurry of activity—our persistence paid off. Legislation to protect
researchers’ working with animals, the Animal Enterprise Terrorism Act (AETA), was passed
by the House and Senate and signed by the President in late November. FASEB worked
closely with the National Association for Biomedical Research, the driving force behind
AETA, and mobilized the scientific community in support of this important legislation. In
December, as the FASEB Board was holding its meeting, the NIH Reform Act was passed by
the House and Senate. To express his gratitude for our role in shaping the legislation to
meet the concerns of scientists, Joe Barton, Chair of the House Energy and Commerce
Committee, traveled to Rockville, Maryland, to thank the Board personally for FASEB’s sup-
port on this measure. The ultimate impact of our advocacy on the FY 2007 funding bills
did not completely play out until the first few weeks of 2007, when Congress passed the FY
2007 Joint Funding Resolution that contained a $619 million increase for the NIH plus
major increases in funding for NSF and DOE. The additional funds for research were the
3
P r e s i d e n t ’ s R e p o r t[ ]
Leo Furcht, M.D.
4
result of strong actions by our chief supporters in Congress, but FASEB’s work mobilizing scien-
tists did not go unnoticed; a Nature editorial cited FASEB’s advocacy efforts as a major factor
contributing to this outcome.
Much of our success is attributable to the outstanding work of the FASEB staff. Jon Retzlaff
worked tirelessly to convey the views of the research scientists to the House Energy and
Commerce staff working on NIH reauthorization, and as a result, they ultimately came to appre-
ciate and adopt our positions. Carrie Wolinetz has earned the respect of the entire research
community with her finely crafted position statements and widely praised slide presentations
on the benefits of NIH-supported research. A grant from the Office of Research Integrity to
Laura Brockway is enabling us to build a coalition of organizations committed to ensuring that
the views of individual investigators are heard in the policy debate over financial conflict of
interest in academic-industry relations, and resources developed by Jennifer Hobin, Marnie
Halpern, and their colleagues on the Educating About Evolution Subcommittee, which pro-
motes evolution education in the schools, were featured in Science and praised by the National
Center for Science Education.
Certainly one of the highlights of the year was our recruitment of Guy Fogleman, to become
executive director of FASEB. His leadership skills and management expertise were apparent to
all of us who met with him during the interviewing process, and we were very pleased when he
decided to join us in July. In the short time that Guy has been at FASEB he has more than justi-
fied the confidence that we placed in him, and his personal style and attention to the needs of
the organization have dramatically improved the relations between FASEB and the Member
Societies. As we face new and mounting challenges in the future, one thing is certain: with its
new management, FASEB will be in a stronger position to address them.
As a result of our efforts on behalf of the individual investigator in the biomedical and related
life sciences, FASEB’s influence among policymakers has never been greater. Our views on leg-
islation and major research issues are directly solicited by members of Congress and the heads
of major federal agencies. Senior staff are in regular contact with us, seeking our views and
expressing their gratitude for our advice and support.
I am very proud of what we have accomplished and am confident that we face a bright future.
With the active support of the FASEB Member Societies, we will continue to advance research
and education in the biomedical and related life science. n
P r e s i d e n t ’ s R e p o r t
“”
FASEB is a great organization with a distinguished historyand an important mission.
FASEB is a great organization with a distinguished history and
an important mission. I am delighted to have the privilege of
serving as its Executive Director and working with its very tal-
ented and impressive staff. I am mindful of the fact that FASEB
exists because our Member Societies want us to exist and find
value in belonging to this Federation. During my tenure so far, I
have greatly benefited from the counsel of the Society
Executive Officers, both individually and through the Executive
Officers Advisory Committee, and am looking forward to contin-
ued productive and collegial interactions in the future.
FASEB’s volunteer leadership is an essential and integral component of the Federation.
2006 was a year of significant change in FASEB’s governance structure: we successfully
made the transition from two to one Board member from each Member Society. Amid con-
cerns about a smaller pool of potential officers, five people ran for the office of President,
showing that interest in participating in FASEB’s governance continues to be high. Our offi-
cers, Board members, and committee members lead our advocacy and other activities.
They are actively engaged in the oversight and the setting of strategic direction for FASEB
through regular teleconferences and face-to-face meetings.
The many successes of our public affairs activities are enumerated in other sections of this
report, so I will not dwell on them here. But I will say that, under the leadership of our
Deputy Executive Director for Policy, Howard Garrison, 2006 was a year in which FASEB
came into its own as a major player on the national policy scene. One of many measures
of our success in this area is that products of the Office of Public Affairs, such as our state-
specific NIH Advocacy presentations and our Breakthroughs in Bioscience articles, are
increasingly requested and used by the Research Education and Advocacy community.
The FASEB Journal Editorial Board has been very active, holding its first-ever meeting in
New York in May 2006. FJ’s new Editor-in-Chief, Gerald Weissmann, completed his first full
year in that role. The results of their efforts in the style and relevance of the FJ have been
remarkable and were noticed by many; I recently heard FJ referred to as avant-garde.
Financially, 2006 was a good year for FASEB. Scientific meetings (including Summer
Research Conferences) and The FASEB Journal continue to be significant sources of
E x e c u t i v e D i r e c t o r ’ s R e p o r t[ ]
Guy Fogleman, Ph.D.
5
6
revenue for the organization. Based on projections from the FASEB financial model developed
by our Deputy Executive Director and Chief Financial Officer, Anthony Fragnito, we determined
that it would be beneficial to pre-fund our 2007 debt service requirement (associated with the
new office building and parking structure on the Beaumont campus) during 2006. The strength
of our investment portfolio also served FASEB well in 2006. We took advantage of favorable
conditions in the bond markets to execute an interest rate swap contract tied to the tax-exempt
bond used to finance our campus construction activities. This “swap”had the same effect as
converting from a floating rate mortgage to a fixed rate mortgage, locking in a very good inter-
est rate. We are also pleased that the Association for the Accreditation of Human Research
Protection Programs, an organization for which FASEB is a founding partner as well as a finan-
cial guarantor, is becoming stable financially.
Our beautiful campus in Bethesda underwent several upgrades in 2006. We retrofitted the old-
est (circa 1960s) sections of the Lee Building with a new sprinkler system for fire suppression.
We also completed a pass-through at the back of the FASEB campus that allows those who
work on campus to exit by automobile in a considerably safer and more convenient manner.
Our Managed Society Services Department completed its first full year of operation, successful-
ly bringing six new clients (all biology-or biomedical-oriented associations) under contracts for
management services. This increased activity also created additional business for other FASEB
departments. FASEB departments continue to provide financial, information technology, pro-
duction and postal, meetings management, human resources, dues and subscriptions, and pub-
lishing services to our Member Societies as well as to other biology-oriented associations.
One significant value that FASEB provides for our Member Societies is through the Minority
Access to Research Careers (MARC) program, which is funded by grants from the National
Institute of General Medical Sciences’ Division of Minority Opportunities in Research. The
MARC program sponsored 382 travel awards to Member Society scientific meetings, Summer
Courses, and Summer Research Conferences. In addition, 79 awards to participate in FASEB
Summer Research Opportunity Programs were sponsored through the MARC program. FASEB
also received several grants from the Burroughs Wellcome Fund in 2006, including a $15,000
grant to support a new FASEB Diversity Award, with a commitment to continue funding this
award for five years.
While we have had significant successes, we know that FASEB has a number of challenges
going forward: How do we best set priorities for advocacy in the era post the doubling of the
NIH budget? How will FASEB be affected by the trend that a growing proportion of many of
our Societies’ members are from outside the US? What are the options for the long-term
E x e c u t i v e D i r e c t o r ’ s R e p o r t
evolution of the FASEB campus? What strategies and goals should FASEB set as the Federation
approaches its centennial in 2012? I am confident that FASEB’s staff, together with our
volunteer leadership and our partners in the Member Societies, will be able to rise to these
challenges.
My vision for the future of FASEB revolves around three key themes: Leadership, Financial
Stability, and Workforce Development. With respect to leadership, FASEB must continue to be a
major force in national biomedical research policy, and must be proactive in providing state of
the art and cost effective services to our Member Societies. Our finances need to be such that
our revenue covers operations plus routine deposits to our reserve fund, enabling our reserve
fund to grow even with occasional withdrawals for Board-approved special projects. I would
like FASEB to be a great place to work for our employees and for all the organizations that call
our campus home. Initial steps were taken in these directions in 2006. After carefully studying
the FASEB organization, I restructured the reporting relationships for FASEB departments so
that they are grouped according to their major functions, and restructured the FASEB
Executive Office so that we can be increasingly open and responsive to the needs of the
organization. We have also initiated a working group of FASEB employees to review and make
recommendations on workforce development issues.
I believe that FASEB’s role in the future, as a primary advocate for research and as a provider
of critical services to our Member Societies, will only increase in importance. I am very much
looking forward to working with all of our stakeholders to ensure FASEB’s success in these
areas. n
“”
My vision for the futureof FASEB revolvesaround three keythemes: Leadership,Financial Stability, andWorkforce Development.
7
E x e c u t i v e D i r e c t o r ’ s R e p o r t
F A S E B O f f i c e o f P u b l i c A f f a i r s[ ]
8
Advocacy for biomedical research and shaping of
related policies on behalf of working scientists are
the chief missions of the FASEB Office of Public
Affairs (OPA).Working with FASEB leadership,
Member Society staff, government officials, and advo-
cacy partners, the OPA staff helps to facilitate a pro-
ductive exchange among the scientific community,
the Federal government, and the public. FASEB’s rep-
utation as the voice of the biomedical research com-
munity is such that when issues related to science
arise, legislators, federal agencies, and other organiza-
tions come seeking FASEB’s views.
FASEB: A Strong Voice for Biomedical
Research: 2006, Year in Review
While the announcement of the President’s American
Competitiveness Initiative (ACI), which proposed to
double the funding for science at the National
Science Foundation and Department of Energy’s
Office of Science, was welcomed news to the scientif-
ic community, the funding prospect for the National
Institutes of Health (NIH) appeared grim. The
President’s budget called for flat-funding of NIH and
Congress seemed determined to maintain a fiscal
standard that would not have allowed additional dol-
lars for medical research. FASEB began the year with
an aggressive advocacy strategy, taking aim at the
congressional budget resolution, and in response to
FASEB’s call to action, nearly 9,000 letters were gener-
ated by scientists, resulting in passage of an amend-
ment to allow greater funding for health and educa-
tion programs, including NIH. This was merely the
first volley in a year-long effort to generate grassroots
activity and maintain FASEB’s high-profile on Capitol
Hill, ultimately culminating in a significant increase
for NIH in FY 2007.
Funding for biomedical research was only one of
many issues addressed by FASEB in 2006. It was a
year marked by the first presidential veto on embry-
onic stem cell legislation, successes in defeating pro-
posed export regulations that could have dramatical-
ly affected academic researchers, and FASEB’s efforts
on behalf of young scientists. On July 1st, FASEB
President Leo T. Furcht, succeeded Bruce R. Bistrian,
in leading the Federation on issues related to NIH
reauthorization, conflict-of-interest, embryonic stem
cells, the use of animals in research, and other policy
issues of crucial importance to the scientific
community.
FASEB Plays Pivotal Role in
Shaping the Future of NIH
One of the final actions of the 109th United States
Congress was to pass the National Institutes of Health
Reform Act, a landmark piece of legislation that reau-
thorized the NIH for the first time in more than 13
years. In cooperation with Chairman Joe Barton (R-
TX) of the House Energy and Commerce Committee,
FASEB played a major role in shaping, improving, and
ultimately passing the NIH reauthorization bill.
Through the tireless efforts of FASEB Legislative
Government& Legislative
Liaison
FASEBOffice of
Public Affairs
PublicOutreach
PolicyDevelopment
CoalitionBuilding
Communication
Research& Analysis
F A S E B O f f i c e o f P u b l i c A f f a i r s
Director Jon Retzlaff and President Leo Furcht, FASEB
had exclusive input into the developing legislation,
resulting in a vision for NIH that emphasized investi-
gator-initiated research, improved transparency, and
sustainable funding levels. President Furcht testified
before the House Energy and Commerce Committee
in September in support of the NIH Reform Act, and
Chairman Barton credited FASEB’s efforts during an
appearance at the December meeting of the FASEB
Board of Directors. During a successful attempt to
defeat amendments to the bill that would have ear-
marked programmatic funds for NIH, a FASEB letter
in opposition to targeted research funding was read
on the House floor. Following nearly unanimous pas-
sage by both houses of Congress, the bill was signed
into law by President Bush.
Advocacy Triumph Results
in Significant Boosts to
Research Funding
FASEB’s efforts to influence the Senate and House
Budget Resolutions resulted in passage of amend-
ments to significantly increase the discretionary pool
available for medical research and other health pro-
grams. FASEB continued its campaign during the
second annual FASEB Capitol Hill Day in which more
than two dozen scientists from the Board of Directors
and Science Policy Committee met with their legisla-
tors and key members of congressional leadership.
The Federation’s efforts drew widespread national
attention in articles published in the Wall Street
Journal, USA Today, and with interviews with the
FASEB President on National Public Radio and
CNBC. Record numbers of scientists contacted mem-
bers of Congress, answering FASEB’s call to action to
increase funding for NIH. Victory was accomplished
upon completion of the FY 2007 funding process,
which contained a $620 million increase for NIH, a
remarkable achievement at a time when most federal
programs received no increase at all.
In addition to the substantial increase for NIH, the
National Science Foundation (NSF) and Department
of Energy also fared well in FY 2007, each receiving a
significant increase over the previous fiscal year.
FASEB strongly supported the President’s proposal
and subsequent congressional legislation to double
the budgets of these two critical agencies. When the
competitiveness legislation and NSF’s proposed strate-
gic plan excluded the biological sciences, FASEB suc-
cessfully campaigned for correction of these over-
sights. As a cosponsor of the National Academies
convocation on its influential report Rising Above the
Gathering Storm, FASEB expressed its support for an
increased investment in all sciences, as well as
science education. In addition to NIH, NSF, and DOE,
the competitive research portfolio of the United
States Department of Agriculture, another program for
which FASEB advocates, received an increased
funding level of $190 million.
Continued Leadership on Conflict of
Interest Gains National Attention
FASEB’s activities regarding conflict of interest issues
were recognized in July when Laura Brockway of
OPA received a grant of $112,000 from the NIH Office
of Research Integrity (ORI) to address conflict of
9
FASEB Board Members present the 2006 FASEB Public Service Award toRepresentative Mike Castle (R-DE) for his tremendous leadership and outstandingcommitment to health programs, including NIH.
interest management in biomedical research. The
grant, funded through a collaborative program
between ORI and the Association of American
Medical Colleges, supports an extension of the work
described in the FASEB report, Shared Responsibility,
Individual Integrity: Scientists Addressing Conflicts of
Interest in Biomedical Research, which detailed the
results of a consensus conference organized by
FASEB to provide guidelines for scientists engaged in
academic-industrial partnerships. The ORI-funded
project is focusing on forming a coalition of scientific
societies, establishing a new consensus on standards
of conduct, and developing educational materials for
use by scientists. FASEB’s project received national
press coverage and articles on FASEB’s endeavors
were accepted for publication in The FASEB Journal
and Journal of the American Medical Association.
FASEB Helps Pass Historic Animal
Rights Terrorism Legislation
On November 27, 2006, President Bush signed S. 3880,
the Animal Enterprise Terrorism Act (AETA), into law.
FASEB worked actively to pass this legislation, which
increases protections for researchers targeted by ani-
mal rights extremists, who advocate arson, personal
violence, and vandalism as appropriate means to end
the use of animals in research. In support of the bill,
FASEB submitted testimony and letters to the House
and Senate Judiciary committees, as well as meeting
with congressional staff to convey the importance of
ensuring the security of biomedical researchers.
Scientists throughout the country took action in
response to FASEB alerts, urging Congress to pass the
AETA, an effort that proved victorious.
Unfortunately, activities to hinder animal research con-
tinued on multiple fronts. In May, FASEB took swift
action to defeat animal rights supporters who were
seeking to have language harmful to research added
to the FY 2007 Agriculture Appropriations Bill. The
Federation contacted the chair of the House
Agriculture Appropriations Subcommittee urging that
they reject efforts to deny funding to institutions pur-
chasing animals from Class B Dealers. As a result of
FASEB and the biomedical research community’s vigi-
lance and advocacy, no such limitations were added
in the bill. In addition to a FASEB letter published in
the Baltimore Sun, decrying an opinion piece filled
with misinformation about the use of animal
research, FASEB is continuing to monitor and com-
ment on the Institute of Laboratory Animal Research’s
project to update their report on laboratory animal
pain and distress.
Communicating the Message:
Scientists, Congress and the Public
Now more than ever, biomedical researchers are in
need of a voice to represent their interests to policy-
makers and the public. FASEB’s communication activ-
ities are threefold: bringing the perspective of science
to lawmakers; keeping the research community
informed on science policy issues; and conveying to
the general public the importance of biomedical
research. FASEB has achieved major success in
recruiting scientists to take action in support of bio-
medical research, as shown by the membership of our
e-Action list, which has grown rapidly to include near-
ly 13,000 self-identified science advocates. In an
ongoing effort to develop advocacy tools for use by
scientists, OPA launched two major products in 2006:
a slide presentation for local NIH advocacy and an
evolution advocacy toolkit.As part of its renewed
focus on grassroots activities by member society sci-
entists, FASEB unveiled a customizable slide presenta-
10
F A S E B O f f i c e o f P u b l i c A f f a i r s
tion that scientists, department heads, and deans can
use locally to demonstrate NIH’s impact on human
health. The slide presentation has been praised by
NIH Director Elias Zerhouni and cited in a
Congressional Research Service report as an example
of outreach activities by scientists. OPA is creating
slide presentations relevant to each state, which are
freely available on our website (http://opa.faseb.org)
and is collecting feedback from FASEB member soci-
eties on their usage.
Arming scientists with the tools they need to advo-
cate on behalf of critical issues is also the driving
force of FASEB’s new evolution advocacy toolkit
(www.evolution.faseb.org). This web-based resource
provides a variety of advocacy materials, including
sample letters-to-the-editor and op-ed pieces, modifi-
able PowerPoint presentations, and tips for working
with teachers, testifying at school board meetings,
and contacting public officials. The site, which was
recently highlighted in the journal Science, also pro-
vides background materials and talking points on the
science of evolution, the importance of evolution
education, and the problems with teaching “alterna-
tives.” To market the evolution advocacy toolkit,
FASEB created wearable buttons bearing the slogan
“Teach Evolution, Learn Science”and colorful palm-
cards. These materials have achieved their own pop-
ularity and have been distributed through a wealth of
venues, including the National Academies Koshland
Science Museum and the Marine Biological
Laboratories in Woods Hole, Massachusetts.
FASEB continues to expand its reach through
increased distribution of its Breakthroughs in
Bioscience series, illustrated articles explaining how
basic research results in medical advancement and
which are written for the non-scientist. An article on
11
breast cancer treatment, produced in partnership with
the Endocrine Society, is being distributed to all staff
members of the Susan G.
Komen Foundation and
given to patients through the
University of Miami’s Braman
Family Breast Cancer
Institute. In response to a
request from the patient
advocates at the National
Health Council, FASEB also
produced a brochure based
on the Breakthroughs series
titled “Science Fortune,”
which explains the role serendipity plays in biomedical
research discoveries.
Office of Public Affairs
Publications in 2006:
• Recommendations for Federal Funding for Biomedical
Research and Related Life Science Research – FY2008
(http://opa.faseb.org/ pdf/final_funding_ fy2008.pdf)
• Garrison, H. H., and Palazzo, R. E. (2006) What’s happen-
ing to the young investigator? The FASEB Journal.
20:1288–1289.
(http://www.fasebj.org/cgi/content/full/20/9/1288)
• Breast Cancer,Tamoxifen,and Beyond: Estrogen and
Estrogen Receptors,Breakthroughs in Bioscience
#21[in partnership with The Endocrine Society]
(http://opa.faseb.org/pdf/Breast_Cancer_Breakthru.pdf)
• Shared Responsibility, Individual Integrity: Scientists
Addressing Conflicts of Interest in Biomedical Research
(http://opa.faseb.org/pdf/FASEB_COI_paper.pdf)
• Science Fortune: How Unpredictable Research
Advances Have Saved Millions of Lives
(http://opa.faseb.org/pdf/ScienceFortuneBrochure.pdf)
F A S E B O f f i c e o f P u b l i c A f f a i r s
C o l l a b o r a t i v e E f f o r t s
Collaboration is inherent in FASEB’s coalition struc-
ture. The strength of the Federation lies in its com-
bined representation of its societies and their mem-
berships. FASEB also serves as a partner in coopera-
tive efforts, not only with external organizations, but
with its own members societies, working together to
achieve common goals.
Working Together in
Public Affairs
FASEB’s unique relationship with its Member
Societies allows collaborative activities that serve the
interests of both the coalition and individual society
members. Nowhere is this more evident that in
FASEB’s public affairs program. A few examples of
FASEB and its Member Societies taking advantage of
the opportunity to fulfill their missions together are
listed below.
• The Endocrine Society sponsored the FASEB
Breakthroughs in Bioscience article titled “Breast
Cancer,Tamoxifen, & Beyond: Estrogen and
Estrogen Receptors.” This joint effort has been a
great success, with nearly 5,000 copies of the article
having been distributed in partnership with
Endocrine Society members, the Susan G. Komen
Breast Cancer Foundation, and the Braman Family
Breast Cancer Institute.
• The American Society for Biochemistry and
Molecular Biology and FASEB united in an effort
to provide evolution advocacy tools to scientists
interested in preserving the integrity of science edu-
cation. All ASBMB members received palm cards
advertising the resources available in the toolkit in
the regular membership mailing. The palm cards
and matching evolution advocacy buttons were
12
Behind the Scenes – Public affairs Staff
LAURA BROCKWAY (Senior Science Policy Analyst) coordi-
nates the activities of the Science Policy Committee, and
is responsible for issues related to public access to sci-
entific literature, academic-industry relations, and tech-
nology transfer. She is the key staff member on FASEB’s
ongoing project related to conflicts of interest in bio-
medical research.
HOWARD H. GARRISON (Deputy Executive Director for
Public Affairs; Director,Office of Public Affairs) directs the
office and coordinates OPA activities with FASEB lead-
ership and society staff. In addition, He prepares
detailed analyses of trends in NIH funding and training
opportunities for scientists, which are used to bolster
OPA’s advocacy activities.
JENNIFER HOBIN (Science Policy Analyst) is responsible
for training and career development issues, including
those related to clinical research. She also directs
FASEB’s efforts related to the teaching of evolution.
SUZANNE PRICE (Communications Assistant) is responsi-
ble for the redesign and maintenance of the OPA web-
site, as well as editing and distributing press releases,
communication products, and reports. In addition, she
is tasked with customizing and updating FASEB’s state-
by-state NIH advocacy presentations.
JON RETZLAFF (Director, Legislative Relations) is FASEB’s
full-time presence on Capitol Hill, where he is able to
gather the most recent and relevant information, and to
assure congressional access for FASEB’s elected leader-
ship. His responsibilities include monitoring relevant
legislative developments, coordinating legislative strate-
gy with FASEB leadership, and directing FASEB’s com-
munications with members of Congress and their staffs.
CARRIE D. WOLINETZ (Director,Communications) directs
OPA communications with Member Societies, the
media and the general public. She is also responsible
for issues related to animal research, SCNT/stem cells,
and homeland security.
C o l l a b o r a t i v e E f f o r t s[ ]
13
also distributed at the annual meetings of The
American Society of Human Genetics, Society
for Developmental Biology, The American
Physiological Society, and The American
Society for Bone and Mineral Research.
• FASEB generates a monthly Washington Update
column for the American Society for
Biochemistry and Molecular Biology’s monthly
magazine, ASBMB Today, which informs ASBMB
members of FASEB’s government affairs activities.
The Office of Public Affairs has also contributed
periodic articles to the newsletters of The Protein
Society, American Association of Anatomists,
and American Society for Investigative
Pathology.
• FASEB provided its legislative alert system to The
American Physiological Society to enhance joint
efforts to halt legislation that would have would
have restricted biomedical research funding for
studies using animals purchased from Class B dealers.
Serving Scientists through
Cooperative Efforts
The service departments at FASEB work both for and
with the FASEB Member Societies. From Career
Resources to the Office of Scientific Meetings, the
pooled resources and combined efforts of FASEB and
its societies unite to serve the biomedical research
community.
• The FASEB Minority Access to Research Careers
(MARC) Program provides funding for travel awards
to support the participation of faculty/ mentors and
students, and poster/platform (oral) presenters at
Member Society meetings and conferences, as well
as FASEB Summer Research Conferences. This has
included awards to attend meetings of nearly every
FASEB Member Society, as well as sponsorship of
workshops or speakers at the meetings of the
American Society for Pharmacology and
Experimental Therapeutics, American Society
for Investigative Pathology, American
Association of Anatomists, and Society for
Developmental Biology.
• FASEB Member Societies, including the American
Society for Clinical Investigation, The
American Society for Bone and Mineral
Research, The American Society for Human
Genetics, The American Association of
Immunologists, and the societies participating in
the Experimental Biology Meeting, have part-
nered with FASEB’s Office of Scientific Meetings for
educational activities associated with continuing
medical education.
• In 2006,The Endocrine Society joined FASEB to
cosponsor part of FASEB’s highly successful Summer
Research Conference (SRC) series. The SRC pro-
gram is itself a collaborative effort, with members of
the FASEB societies serving on the SRC Advisory
Committee and selecting conferences from propos-
als submitted by FASEB Member Societies.
• The FASEB Career Resources program was involved
in numerous cooperative efforts with FASEB soci-
eties throughout the year, including providing virtual
career fair services at the meetings on The
American Association for Immunologists and
The American Society for Human Genetics. n
C o l l a b o r a t i v e E f f o r t s
EXECUTIVE OFFICERS ADVISORY COMMITTEE,
Guy Fogleman, Chair
The Executive Officers Advisory Committee (EOAC)
is a standing committee of the Board, that “shall
address itself to items of mutual interest to the
Federation and the Member Societies”(FASEB
Bylaws,Article VII, Section 3). The EOAC met
approximately twice a month in 2006 and consid-
ered a wide range of issues. Each meeting was
divided into two sections, one dealing with cross-
cutting issues of interest to all of the societies (e.g.,
the advocacy agenda, Continuing Medical
Education applications, FASEB finances, meeting
planning, publications,Association Management
System software packages, etc.) and one limited to
issues of primary concern to those societies resid-
ing on campus (e.g., FASEB services, building and
grounds, conference center usage, etc.). Reports of
activities of each FASEB Member Society are pre-
sented to the EOAC for the joint purposes of infor-
mation sharing and soliciting advice. The EOAC
continues to review and develop positions on all of
the major issues brought to the FASEB Board.
EOAC Members
Guy C. Fogleman (FASEB)
Martin Frank (APS)
Barbara Gordon (ASBMB)
Christine K. Carrico (ASPET)
Mark E. Sobel (ASIP)
John Courtney (ASN)
M. Michele Hogan (AAI)
Andrea Pendleton (AAA)
Cindy A.Yablonski (Protein)
Ida Chow (SDB)
Jane V.Aldrich (APepS)
Jay W. Fox (ABRF)
Ann Elderkin (ASBMR)
John Hawley (ASCI)
Judith Jansen (SSR)
Tonia Masson (Teratology)
Scott B. Hunt (TES)
Elaine Strass (ASHG)
Ava Tayman (SGI)
Tonia Masson (EMS)
B. J. Morrison McKay (ISCB)
Jim Whitehead (ACSM)
F A S E B C o m m i t t e e s[ ]
FASEB’s strength in advocating for biomedical research is its diversity of disciplines and the large number of sci-
entists it represents. In order to ensure that the views of all Member Societies and the researchers they represent
are heard, FASEB is guided by its Board of Directors as well as committees focused on areas such as public
affairs, research conferences, and publications.
14
15
EXECUTIVE COMMITTEE, Leo T. Furcht, Chair
As directed by the FASEB Bylaws (Article VII, Section
2, available on the FASEB web site), the Executive
Committee is a standing committee of the Board that
consists of the officers of the Board. The Committee
meets weekly to “exercise the management authority
of the Board of Directors in between meetings of the
Board of Directors.”
In 2006, with rare exceptions, the Committee met
weekly with the Director of the Office of Public
Affairs and the Chief Financial Officer to review the
events of the week. The agenda is usually divided
equally between issues related to advocacy by the
organization and issues related to the business func-
tions of the FASEB campus.
The business of running FASEB is reviewed with spe-
cial attention to fiscal matters for review and
approval by the Finance Committee, campus issues,
and relationships with FASEB Member Societies,
managed societies, and nonmember societies. The
activities of other committees of FASEB are reviewed
weekly, as needed, including the agendas of the
Executive Officers Advisory Committee, the
Department Heads Meetings, etc. Planning of FASEB
Board Meetings is also a function of this committee,
as is the general oversight of FASEB staff. The voting
officer members of the Executive Committee make
up the Nominating Committee and recommend a
slate of candidates for election as officers of the
organization.
Executive Committee Members
Leo T. Furcht
Robert E. Palazzo
Bruce R. Bistrian
Kenneth G. Mann
John A. Smith
Guy C. Fogleman
PUBLIC AFFAIRS COMMITTEE, Robert E. Palazzo, Chair
The Public Affairs Committee (which is made up of
the members of the Executive Committee together
with two Board Members elected annually) meets
monthly to respond to issues generated by the
Executive Committee and assist in prioritization for
the SPC and the Board. In 2006, the PAC began to
hold semiannual face-to-face meetings to set long-
term pubic affairs priorities for the Federation.
Public Affairs Committee Members
Robert E. Palazzo
Richard B. Marchase
Leo T. Furcht
Bruce R. Bistrian
Mark Lively
Kenneth G. Mann
David B. Bylund
John A. Smith
Paula H. Stern
Howard H. Garrison*
Guy C. Fogleman*
*Ex officio, non-voting
THE SCIENCE POLICY COMMITTEE,
John Smith, Chair
The Science Policy Committee (SPC) is FASEB’s
“think-tank”and is charged with developing long-term
policies and consensus positions on issues of con-
cern to biomedical researchers. Previous chair of the
SPC,Vice-President for Science Policy Richard
Marchase, completed his term of office on June 30
and was succeeded by John Smith. Primarily working
through standing or ad hoc subcommittees, the SPC
became actively engaged in 2006 in several issues of
critical importance to the biomedical research com-
mittee, the highlights of which are detailed below.
F A S E B C o m m i t t e e s
Responding to Emerging Issues:
Peer Review Subcommittee
In June, the SPC held a joint symposium with the
FASEB Board of Directors entitled,“Peer Review:
Issues, Mechanisms, and Models.” The purpose of the
symposium was to initiate a discussion of the current
challenges faced by the NIH Center for Scientific
Review (CSR) and proposed solutions. Speakers
included: Elias Zerhouni, NIH Director; Antonio
Scarpa, CSR Director; Gerald M. Rubin,Vice-President
and Director, Janelia Farm Research Campus, Howard
Hughes Medical Institute; and Keith R.Yamamoto,
Professor and Executive Vice Dean, School of
Medicine, University of California San Francisco. As a
result of the symposium, FASEB formed a new sub-
committee on peer review, which has been actively
engaged in dialogue with Antonio Scarpa in making
recommendations for meeting the needs of the scien-
tific community in regard to peer review. Given the
crucial importance of this issue for biomedical
researchers, and its complexity, it is likely this new
subcommittee will play a significant role in future
FASEB policy development.
Serving the Next Generation:
Training and Career Opportunities
for Scientists
The Training and Career Opportunities subcommittee
of the SPC engaged in a number of activities through-
out 2006 that were related to serving the next genera-
tion of biomedical researchers. The subcommittee
has been especially concerned with meeting the
needs of postdoctoral fellows and initiated a joint
statement with the Association of American Medical
Colleges (AAMC) on uniform health benefits for post-
doctoral scientists. FASEB also joined with AAMC in
commenting on proposed changes to the Ruth L.
Kirschstein National Research Service Awards tuition
funding policy, and our suggestion that health bene-
fits be separated from calculation of tuition was ulti-
mately adopted by NIH. In addition, the subcommit-
tee has been working on a number of projects related
to career development issues of scientists, including a
proposal funded by the National Science Foundation
to use the SESTAT data base to examine scientific
career outcomes and continued efforts to facilitate
the use of FASEB’s Individual Development Plan for
postdoctoral scientists. The Training and Career
Opportunities subcommittee serves as a liaison
between the policy development functions of the SPC
and services provided by the Career Resources and
MARC programs.
Serving Science and Society: Enhanced
Access to Scientific Publications
Through the SPC’s Enhanced Public Access
Subcommittee, FASEB continues to support efforts to
increase access to scientific publications without dis-
rupting the successful model of scientific publication
established by not-for-profit scientific societies. The
subcommittee facilitated FASEB’s participation in a
proposal, together with nearly five dozen other organi-
zations, to establish a public-private partnership with
NIH that would meet the needs of both the federal
agency and the scientific society publishers. The
group monitors and reports on the activities of the
National Library of Medicine’s PubMed Central
Advisory Committee and Public Access Working
Group, which are spearheading NIH’s efforts to man-
date access to published information. On the legisla-
tive front, the Enhanced Public Access Subcommittee
worked to defeat efforts to add deleterious language
regarding “open access”publication to the appropria-
tions bill that funds NIH, as well as strongly opposing
the Federal Research Public Access Act of 2006.
This bill, sponsored by Senators John Cornyn (R-TX)
and Joseph Lieberman (D-CT), would have mandated
that all federally funded research results be made
available online within six months of publication. Via
the SPC committee, FASEB expressed concern that the
legislation jeopardizes crucial processes, such as peer
review, and hinders scientific societies’ ability to pro-
vide services to the scientific community and the
16
F A S E B C o m m i t t e e s
17
public. Although the advocacy efforts of FASEB
proved successful in preventing the bill from passing
the Senate committee to which it had been referred,
the subcommittee continues to monitor and address
similar legislation.
Subcommittees and Chairs of the
Science Policy Committee, 2006
• Animals in Research and Education Issues,
William Talman (APS)
• Breakthroughs in Bioscience, Fred Naider (ApepS)
• Clinical Research, Janet Hall (Jan.-Aug.) and Jane
Reusch (Sept.-Dec.) (Endocrine)
• Educating About Evolution, Marnie Halpern (SDB)
• Enhanced Public Access Committee,
Patsy Brannon (ASN)
• NIH Issues, Robert Palazzo (ASBMB)
• Peer Review, Gail Bishop (AAI)
• Stem Cells & SCNT Subcommittee,
Peter Mathers (SDB)
• Training and Careers Subcommittee,
Joseph LaManna (AAA)
SPC Members
John A. Smith (APepS),
Vice President for Science Policy**
William T.Talman (APS)
Peter A. Rubenstein (ASBMB)
Henry R. Besch, Jr. (ASPET)1
James E. Barrett (ASPET)
Avrum I. Gotlieb (ASIP)
Patsy M. Brannon (ASN)
Gail A. Bishop (AAI)
Joseph C. LaManna (AAA)
A. Joshua Wand (Protein)
Marnie E. Halpern (SDB)
Peter H. Mathers (SDB)
Ted Thannhauser (ABRF)
Larry Suva (ASBMR)
David H. Gutmann (ASCI)
Joanne Fortune (SSR)
Thomas B. Knudsen (Teratology)
Jane E. Reusch (TES)
Nanette Santoro (SGI)
Jeffrey L. Schwartz (EMS)
Greg Tucker-Kellogg (ISCB)
Charlotte (Toby) A.Tate (ACSM)
Mark O. Lively (ABRF),
Vice President-Elect for Science Policy
Richard B. Marchase,
Past Vice President for Science Policy
Howard H. Garrison - Deputy Executive Director for
Policy; Director, Office of Public Affairs (FASEB)*
Guy C. Fogleman - Executive Director (FASEB)*
1Deceased March 17, 2007
**Non-voting; *Ex-officio, non-voting
EXCELLENCE IN SCIENCE AWARD COMMITTEE,
Marianne Wessling-Resnick,Chair
The Excellence in Science Award is sponsored by Eli
Lilly and Company to recognize outstanding achieve-
ment by women in biological science. All women
who are members of one or more of the societies of
FASEB are eligible for nomination. Nominations rec-
ognize a woman whose career achievements have
contributed significantly to further our understanding
of a particular discipline by excellence in research
and who is an outstanding mentor for young scien-
tists at all levels of development.
An extraordinarily large and strong pool of women
scientists nominated for the Excellence in Science
Award has made the selection of winners difficult for
the past several years. In 2006, 82 nomination pack-
ages meeting award criteria were received and the
committee ultimately selected two recipients—Dr.
Marilyn Farquahr and Dr. Elaine Fuchs. The
Excellence in Science Award Committee fully antici-
pates an even greater response in 2007, and FASEB is
grateful for their efforts devoted to an intense review
of these highly accomplished scientists.
F A S E B C o m m i t t e e s
Excellence in Science Award
Winners 2006
Marilyn Farquahr has been
Professor and Chair of
Cellular and Molecular
Medicine at the University
of California San Diego
since 1990 and previously
held positions as Professor
of Pathology at the UCSF
School of Medicine,
Professor of Cell Biology at
Rockefeller University, and Sterling Professor of Cell
Biology at Yale University School of Medicine. She is
recognized for her seminal work in the regulation of
protein trafficking and signaling in endocrine and
exocrine cells as well as for defining the molecular
mechanisms of glomerular filtration and pathology.
She has published nearly 300 papers in prestigious
journals and has trained over 40 postdoctoral and
graduate students. She is a member of the National
Academy of Sciences and the American Academy of
Arts and Sciences and has received the Wilson Medal
of the American Society of Cell Biologists, the Homer
Smith Medal of the American Society of Nephrology,
the Distinguished Scientist Medal of the EMSA, the
Chancellor’s Award for Excellence in Research
(UCSD), the Rous-Whipple Award of the American
Society for Investigative Pathology, and the A. N.
Richards Award for Excellence in Research from the
International Society of Nephrology. She has served
as President of the American Society of Cell Biology,
on the editorial boards of the Journal of Cell Biology,
the Journal of Clinical Investigation and Molecular
Medicine, and currently serves on the Editorial Board
of Molecular Biology of the Cell and as Associate
Editor of the Journal of Histochemistry and
Cytochemistry. She received her Ph.D. from the
University of California Berkeley and San Francisco,
and did postdoctoral work at the University of
California San Francisco and the Rockefeller
University. Her current work is focused on studying
the spatial regulation of signaling mediated by protein
trafficking and targeting along the exocytic and endo-
cytic pathways with emphasis on novel functions of G
proteins on intracellular membranes.
Elaine Fuchs is currently
Rebecca C. Lancefield
Professor and Head of the
Laboratory of Mammalian
Cell Biology and
Development, Rockefeller
University, as well as an
Investigator for the Howard
Hughes Medical Institute.
She is a world leader in
skin biology and its human genetic disorders, which
include skin cancers and life-threatening genetic syn-
dromes such as blistering skin disorders. Early in her
scientific career, she focused on the molecular mech-
anisms that underlie the development and differentia-
tion of the epidermis and its appendages from multi-
potent stem cells. Throughout her studies, she has
continually used the basic biology she has uncovered
to elucidate how perturbations of these mechanisms
result in disease. She has systematically applied
molecular and genetic approaches to these problems.
In doing so, she pioneered the use of “reverse genet-
ics,”a then unconventional but now textbook
approach to understanding how proteins function
and then work up to the human diseases they cause
when defective. She initially conceived and applied
this strategy to elucidate the functions and genetic
basis of the first intermediate filament disorder, now a
group of nearly 20 related but distinct human disor-
ders. Recently, she has applied her findings to devise
creative approaches for identifying, isolating, and char-
acterizing the multipotent stem cells from skin and
determining how they respond to various external
cues to select their fates to become hair follicles,
sebaceous glands, or epidermis. In addressing the
problem of the progression from stem cell to tissue,
her laboratory now investigates how cells coordinate
changes in transcription, cell polarity, adhesion, and
18
Marilyn Farquahr, Ph.D.
F A S E B C o m m i t t e e s
Elaine Fuchs, Ph.D.
cytoskeletal dynamics. She is widely credited for
bringing dermatology into modern science and has
published over 200 papers, mostly in high profile sci-
entific and medical journals. She received her Ph.D.
in Biochemistry from Princeton University in 1977.
She conducted postdoctoral research at the
Massachusetts Institute of Technology in the laborato-
ry of Howard Green. In 1980, she joined the faculty at
the University of Chicago. When she left Chicago to
accept a position at The Rockefeller University in
2002, she was the Amgen Professor of Basic Sciences.
Among her many awards and honors are the
Presidential Young Investigator Award, the Richard
Lounsbery Award from the National Academy of
Sciences, the Novartis-Drew Award for Biomedical
Research, and the Dickson Prize in Medicine. She is a
member of the National Academy of Sciences, the
Institute of Medicine of the National Academy of
Sciences, and the American Academy of Arts and
Sciences. She holds an honorary doctorate from Mt.
Sinai-New York University School of Medicine, is a
past President of the American Society of Cell
Biology, and was recently elected to the American
Philosophical Society.
Excellence in Science Award
Committee Members
Marianne Wessling-Resnick (ASN)
Siribhinya Benyajati (APS)
Margaret Offermann (ASBMB)
Laura Nisenbaum (ASPET)
Nancy L.Thompson (ASIP)
Mercedes Rincón (AAI)
Maya Sieber-Blum (AAA)
Lisa M. Gloss (Protein)
Catherine E. Krull (SDB)
Nancy D. Denslow (ABRF)
Jane B. Lian (ASBMR)
Suzanne D. Conzen (ASCI)
Mary B. Zelinski (SSR)
Henry M. Kronenberg (TES)
Judith L.Turgeon (TES)
19
Robert Nussbaum (ASHG)
Florence Haseltine (SGI)
Karen M.Vasquez (EMS)
Anne B. Loucks (ACSM)
Guy C. Fogleman – Executive Director (FASEB)*
*Ex-officio, non-voting
FINANCE COMMITTEE,
Kenneth Mann, Treasurer and Chair
FASEB operations and the return from its invested
assets continued to improve in 2006. The reserves
contributed almost $550K in interest and dividend
income, after subtracting management expenses, and
recorded over $1M in realized gains. The contribu-
tions from the campus support services,The FASEB
Journal, and the FASEB Summer Research Conference
program all exceeded budget. While our progress
leasing space in the Lee Building has been slower
than hoped for (primarily due to use restrictions), we
remain optimistic that we will fill a majority of the
available space in 2007.
During 2006, the Finance Committee:
• Evaluated the final report and management recom-
mendations from an independent study commis-
sioned to evaluate FASEB’s compensation manage-
ment plan. The study reviewed benchmark positions
against survey data for like organizations and includ-
ed a direct survey.
• Approved the final report and selected recommen-
dations from the Finance Committee Task Force on
Long-Term Fiscal Issues.
• Received detailed presentations, including program
and financial history, on the reserves,The FASEB
Journal, and the Summer Research Conference pro-
grams. The committee discussed program chal-
lenges and opportunities for these significant finan-
cial contributors.
F A S E B C o m m i t t e e s
• Executed a swap contract to effectively fix the inter-
est rate on the bonds used to finance the East Wing
and parking structure construction.
• Recommended to the Board, and received approval
for, a reserve designation for the future renovation
needs of the Beaumont campus.
• Initiated an ad hoc committee of the Finance
Committee to engage society officers in an effort to
pool experience with respect to financial policies
and advisors.
During the next year, we anticipate continuing
face-to-face reviews of the business operations of the
Federation including activities in finances and oppor-
tunities. As this information is developed it is antici-
pated that the Committee will be able to provide
longer term financial projections to the Board.
The Finance Committee recognizes Tony Fragnito, Guy
Fogelman, and the FASEB staff for their diligence in
assisting the Committee.
Finance Committee Members
Kenneth G. Mann (ASBMB)
Ann C. Bonham (APS)
Charles O. Rutledge (ASPET)
Stanley Cohen (ASIP)
Fred D. Finkelman (AAI)
Duane E. Haines (AAA)
Bruce D. Murphy (SSR)
Kathryn W.Tosney. (SDB)
Peter A.Ward (ASIP)
Gerald L. Hazelbauer (Protein)
Terry R. Brown (TES)
James C. Rose (SGI)
Jeffrey L. Schwartz (EMS)
Anthony T. Fragnito – Deputy Executive
Director and Chief Financial Officer (FASEB)*
Guy C. Fogleman – Executive Director (FASEB)*
*Ex-officio, non-voting
PUBLICATIONS AND COMMUNICATIONS COMMITTEE,
David M. Klurfeld,Chair
The FASEB Publications and Communications
Committee (PCC) met in May 2006. The meeting cov-
ered issues from the new online interface for the
FASEB Directory of Members to cross-committee par-
ticipation between the PCC and the FASEB Finance
Committee. A significant portion of the meeting was
spent on items relating to The FASEB Journal. Gerald
Weissmann, the journal’s new Editor-in-Chief, delivered
his first report to the committee. The PCC also heard
reports on journal business and production issues
from the Office of Publications staff. The decision to
discontinue the FJ Express method of publishing, as
recommended by the Editor-in-Chief and supported
by the Editorial Board, was approved by the PCC.
The Editorial Advisory Committee, a subcommittee of
the PCC formed in 2005, changed leadership from
Sam Enna to Tom Baldwin at the May meeting. The
advisory committee was engaged throughout 2006
reviewing editorials and other up-front material for
the journal.
The PCC reviewed and approved a revision to the edi-
torial policies for The FASEB Journal in August. The
PCC was also called upon in November to review an
allegation of misconduct.
PCC Members
David M. Klurfeld (ASN)
Eileen M. Hasser (APS)
Peter A. Rubenstein (ASBMB)
Edward T. Morgan (ASPET)
Jon S. Morrow (ASIP)
Thomas R. Malek (AAI)
Donald A. Fischman (AAA)
Thomas O. Baldwin (Protein)
Sally A. Moody (SDB)
Clive A. Slaughter (ABRF)
Suzanne M. Jan de Beur (ASBMR)
20
F A S E B C o m m i t t e e s
Kai W.Wucherpfennig (ASCI)
Alan L. Johnson (SSR)
Lorraine Fitzpatrick (TES)
Miriam G. Blitzer (ASHG)
Phyllis C. Leppert (SGI)
Robert H. Heflich (EMS)
Scott Markel (ISCB)
Andrew J.Young (ACSM)
Linda C. Giudice (SGI)
Gerald Weissmann – Editor-in-Chief*
Guy C. Fogleman – Executive Director (FASEB)*
*Ex-officio, non-voting
FASEB SUMMER RESEARCH CONFERENCE ADVISORY
COMMITTEE,William A. Muller, Chair
Thirty-three FASEB Summer Research Conferences
were scheduled in 2006.The FASEB Summer
Research Conference Advisory Committee reviews
and selects conferences from proposals submitted by
member and nonmember organizers. Every effort is
made to avoid duplication of conferences. Emphasis
is on cutting-edge research, with prominent scientists
in each field making presentations to attendees who
are heavily engaged in research or are in ancillary
fields where an accurate understanding of allied sci-
entific advances is important. Postdoctoral candi-
dates are also encouraged to participate in the con-
ferences. Attendees are selected by the organizers on
the basis of their probable contributions to science.
Conferences were held at the Vermont Academy,
Saxtons River,Vermont; Snowmass Village, Snowmass,
Colorado; the Omni Tucson Resort,Tucson,Arizona;
and the Hyatt Grand Champions Resort, Indian Wells,
California. Total attendance for all conferences was
3,934 with an average of 124 persons per conference.
Twenty-nine percent of the participants were from
outside the U.S.
21
2006 FASEB Summer Research
Conferences
• AMPK: Impact on Mammalian Metabolism and
Disease (Cosponsored by The Endocrine Society)
• Amyloid Fibril Formation, Protein Misfolding and
Aggregation: Chemistry, Physiology and Disease
• Biological Methylation
• Calcium and Cell Function
• Dynamic Structure of the Nuclear Hormone
Receptors (Cosponsored by The Endocrine Society)
• Folic Acid,Vitamin B12 and One Carbon Metabolism
• Liver Growth, Development and Disease
• Lung Surfactant: Cellular and Molecular Biology
• Lymphocytes and Antibodies
• Mechanisms of Action of Steroid Hormones;
Integration of Membrane- and Nucleus-Mediated
Effects (Cosponsored by The Endocrine Society)
• Mechanisms of Plant Development
• Membrane Organization by Tetraspanins and Small
Multi-Transmembrane Proteins
• Microbial Polysaccharides of Medical Agricultural
and Industrial Importance
• Molecular Biology of Intestinal Lipid Transport and
Metabolism
• Molecular Biophysics of Cellular Membranes
• Neural-Immune Interaction: Pathological
Mechanisms and Repair
• Nucleic Acid Enzymes
• Phospholipases
• Post-transcriptional Control of Gene Expression:
Mechanisms of mRNA Decay
• Poxviruses
• Protein Folding in the Cell
• Protein Lipidation, Signaling and Membrane Domain
• Protein Phosphatases
• Regulation and Function of Small GTPases
• Retinal Neurobiology and Visual Processing
• Retinoids
• Smooth Muscle
• Trace Element Micronutrients: Integrating Basic and
Applied Research
F A S E B C o m m i t t e e s
• Transcriptional Regulation During Cell Growth,
Differentiation, and Development
• Transplantation Immunology
• Ubiquitin and Cellular Regulation
• Virus Assembly
• Yeast Chromosome Structure, Replication and
Segregation
Summer Research Conference
Advisory Committee Members
William A. Muller (ASIP)
Kathryn E. Meier (APS)
George M. Carman (ASBMB)
Jack Bergman (ASPET)
Douglas G. Burrin (ASN)
Donna M. Paulnock (AAI)
A.Wayne Vogl (AAA)
Thomas O. Baldwin (Protein)
Gerald B. Grunwald (SDB)
Satya P. Yadav (ABRF)
Robert D. Blank (ASBMR)
Volker Hans Haase (ASCI)
Asgerally T. Fazleabas (SSR)
Douglas M. Stocco (SSR)
Keith L. Parker (TES)
Douglas A. Marchuk (ASHG)
Laura T. Goldsmith (SGI)
Laura J. Niedernhofer (EMS)
Michael Joyner (ACSM)
Guy C. Fogleman – Executive Director (FASEB)*
*Ex-officio, non-voting
MEMBERSHIP COMMITTEE, Mark O. Lively, Chair
The Membership Committee is an ad hoc committee
of the Board charged to make recommendations
regarding membership in FASEB. Specifically, the
charge to the Committee is to: 1) make recommenda-
tions regarding the FASEB Strategic Plan regarding
those specific sections that deal with attracting new
member organizations to FASEB; 2) develop a set of
criteria for new members; 3) develop a list of poten-
tial organizations that FASEB could approach; and 4)
review existing and future applications for FASEB
membership as processed by the Executive Office,
and make recommendations to the Board.
In 2006, the Committee recommended the following
Criteria for Society Membership to the Board: “FASEB
members are scientific societies dedicated to the
advancement of research and teaching in experimen-
tal biology and biomedicine. The individual members
of the societies are engaged in research and educa-
tion in the biological and biomedical sciences.” Four
societies were contacted during 2006 regarding possi-
ble membership in FASEB. This outreach has not yet
resulted in new prospects for FASEB membership.
It is anticipated that the Membership Committee will
continue to prioritize additional societies for possible
membership in FASEB and to refine the rights and
responsibilities of membership.
Membership Committee Members
Mark O. Lively (ABRF)
Leo T. Furcht – FASEB President
Robert E. Palazzo (ASBMB)
Gregory G. Germino (ASCI)
Jim Rose (SGI)
Martin Frank (APS)
Neil Granger (APS)
Guy C. Fogleman – Executive Director (FASEB)
Anthony T. Fragnito – Deputy Executive Director and
Chief Financial Officer (FASEB)
Howard H. Garrison – Deputy Executive Director for
Policy; Director, Office of Public Affairs (FASEB)
22
F A S E B C o m m i t t e e s
STRATEGIC PLANNING OVERSIGHT COMMITTEE,
Peter A.Ward, Chair
The Strategic Planning Oversight Committee (SPOC)
was developed to provide a review of the objectives
of the Strategic Plan and to report progress to the
Board in meeting those objectives. The Committee
worked closely with the Membership Committee, the
Finance Committee, the Executive Committee, and
the Public Affairs Committee to analyze and make
recommendations regarding FASEB’s future growth,
governance, business model, and biomedical science
advocacy agenda. SPOC, with the support of the
Executive Committee, initiated two task forces: a
Public Affairs Task Force and a Long Term Financial
Issues Task Force. These task forces reported to SPOC
and then to the Board on their recommendations.
SPOC, having successfully completed its major tasks,
was formally disbanded at the December 2006 FASEB
Board meeting.
SPOC Members
Peter A.Ward (ASIP)
Leo T. Furcht – FASEB President
Robert E. Palazzo – FASEB President-Elect
Bruce R. Bistrian – FASEB Past President
Christine K. Carrico (ASPET)
Avrum I. Gotlieb (ASIP)
Mary Lou King (SDB)
John Hawley (ASCI)
Wylie W.Vale (TES)
Garry R. Cutting (ASHG)
George Hoffmann (EMS)
John Smith – Vice President for Science Policy
Richard B. Marchase – Past Vice President for
Science Policy
Mark Lively – Vice President-Elect for Science Policy
Guy C. Fogleman – Executive Director (FASEB)
Anthony T. Fragnito – Deputy Executive Director
and Chief Financial Officer (FASEB)
Howard H. Garrison – Deputy Executive Director for
Public Affairs; Director, Office of Public Affairs
(FASEB)
F A S E B C o m m i t t e e s
23
24
It is just over a year now since a new Editorial Board assumed responsibility for The FASEB
Journal, and we report progress in four areas.
Publishing Performance
In July, responding to an Editorial Board decision, we changed our practice of printing part
of our content as summary versions of fuller manuscripts available online (FJ Express). We
have now reverted to the classic model of a research journal that prints only complete arti-
cles (with e-publication on acceptance after full review). Thanks to this switch, a sparkling
staff, an active, internationally known Editorial Board, and a legion of devoted reviewers,
both the kinetics and demographics of the journal have changed.
Despite decreasing the total number of titles published, we now receive close to 200 IQ
(initial query) submissions per month (vs. 117 in 2004). This rate is constant—we received
over 2000 IQs in 2006 (vs. 1583 in 2004). We have also shortened the turnaround time
between first submission and acceptance to 28 days (vs.103 days in 2004). In consequence,
the bar to publication has been raised: we now accept no more than 10% of papers submit-
ted (vs. 35% in 2004). This barrier has caused no little dismay, and elicited many comments
along the lines of Adlai Stevenson’s definition of an editor as “…a person whose business it
is to separate the wheat from the chaff, and to see that the chaff is printed.”
Scientific Excellence
The quality of our associate editors and board has attracted attention internationally, and
each agrees that the work they review is improving with each month. We are fortunate to
have scientists on board who have founded and/or who dominate the fields in areas for
which they are responsible. These include, among many others, Judah Folkman of Harvard
University (angiogenesis), Salvador Moncada of University College London (nitric oxide),
Peter Lachmann of the University of Cambridge (complement), Jean-Pierre Changeux of the
L’Institut Pasteur, Paris (allosteric controls),Arnold Levine of Princeton University (p53 and
January 2006 January 2004
IQs submitted 186 117
Turnaround (days) 28 103
Papers accepted (last 6 months) 10% 35%
Overall size (pages) 298 223
Research articles 30 12
FJ Express articles 0 37
T h e F A S E B J o u r n a l[ ]
Gerald Weissmann, M.D.Editor-in-Chief
tumor suppression), Helen Blau of Stanford University (cell fusion), George Martin of the
University of Washington (senescence genes), Robert Goldman of Northwestern University
(intermediate filaments), and Etienne Baulieu of INSERM, Paris (RU 486 and steroid hor-
mones). The board also includes members from each society who are eminent in their
own fields. Many board members have had articles submitted from their own labs, and the
institutions at which they work are well represented in the list of articles published.
The Public Face
Thanks in part to a new design, we have attracted the notice of a new public, both on the
web and in libraries. Our covers combine striking images taken from masterpieces of sci-
entific illustration (Haeckel, Leuckart, and Pinson, for example) with short, newsworthy
captions that spell out the cover story. One cover alludes to a detailed geo/biochemical
study of the effects of olive oil on DNA damage and was accompa-
nied by a press release which was picked up by Reuters, and other
media worldwide. The journal’s Managing Editor, Cody Mooneyhan,
has been instrumental in producing and disseminating outstanding
press releases. We have issued a calendar of these covers, which has
been well received. Finally, our frank, open, and extensive editorial
positions in favor of investigator-sponsored research and evolutionary
science, our opposition to faith-based science, intelligent design, and
“alternative medicine”have attracted wide attention. They have been
covered in the columns of Science and the blogs of the Discovery
Institute, come to the attention of our colleagues at the JCI, and
brought rebuttal from the very top of the NIH. Life Science Forum,
Milestones, Book Reviews, and other features have won praise from
our readers—we have become readable.
International Impact
The distribution of our authorship is exactly that of what Thomson
Scientific describes as the world-wide publishing pattern of the “lead-
ing scientific journals in all fields.” In 2006, we received contributions
from 60 countries including the Sudan, Cote Ivoire, Congo, Uzbekistan, Iran, Serbia and
Montenegro, and Vanuatu (vs. 50 in 2004). The United States submitted a plurality, but not
a majority of the work, a fact in keeping with the worldwide patterns of today’s science.
Finally, the editors have sharpened the focus of the journal—we have rejected good work
in order to publish only the best. We recognize that much of what we turn down is indeed
good science and is the product of the latest techniques, the highest of aims, and the most
intricate work. However, the object of intricate science is not the exhibition of intricacy,
but its result. As Henry Higginson of The Atlantic Monthly once quipped “You do not put
guano on your garden that your garden may blossom guano.” We expect our garden to
bloom. n
25
2006 Submissionsa
North Americab 597 32%
Europec 799 43%
Asiad 383 21%
Anzace 50 3%
Middle Eastf 38 2%
South and Central Americag 31 2%
Africah 6 <1%
Total 2082
a43% accepted for review. bUSA: 511, Canada: 86; cUnited Kingdom: 181, Germany:171, France: 115, Italy: 109, Spain: 62, The Netherlands: 35, Switzerland: 32,Belgium: 27, Sweden: 25 Austria: 19, Denmark: 15, Finland: 12, Greece: 11, Portugal:10, Hungary: 8, Norway: 5, Poland: 5, Ireland: 4, Czech Republic: 3, Russia: 2,Luxembourg: 1, Kyrgystan: 1, Uzbekistan: 1; dChina: 121, Japan: 112 , Korea: 78,Hong Kong: 15, Taiwan: 29, India: 15, Singapore: 13; eAustralia: 42, New Zealand: 5;fIsrael: 33, Lebanon: 1, Iran: 3, Jordan: 1; gBrazil: 11 Mexico: 3 Chile: 2, Venezuela: 2;hSouth Africa: 1, Tanzania: 2, Sudan: 1, Ivory Coast: 1, Congo: 1.
T h e F A S E B J o u r n a l
FASEB DEPARTMENTS
Executive Office
Guy C. Fogleman, Executive Director
Anthony T. Fragnito, Chief Financial Officer and
Deputy Executive Director
Howard Garrison, Deputy Executive Director for Policy
Office of Public Affairs
Howard Garrison, Director
Office of Publications
Jennifer L. Pesanelli, Director
Office of Scientific Meetings and Conferences
Geri Swindle, Director
Managed Society Services
Debra L.Weinstein, Director
Accounting and Financial Reporting
David L. Craven, Manager
Contract Financial Services
Iris V. Stratton,Assistant Director
Office of Production and Postal Services
Richard A. Dunn, Director
Information Technology
Guy Riso, Director
Human Resources
Maureen Murphy, Director
Buildings and Grounds
Jeffrey L.Yocum, Facilities Manager
Dues and Subscription Services
Eleanor B. Peebles, Manager
Career Resources and Minority
Access to Research Careers
Jacquelyn Roberts, Manager
FASEB CLIENTS
In addition to the FASEB Member Societies, many
other nonprofit organizations benefit from the prod-
ucts and services provided by FASEB departments.
In 2006, our clients included:
Academy of Certified Hazardous Materials Managers
The American Board of Genetic Counseling
American Board of Medical Genetics
American College of Medical Studies
American College of Toxicology
American Society of Animal Sciences
American Society for Matrix Biology
American Society for Virology
Association for Molecular Pathology
Association for Psychological Type International
Association of Pathology Chairs
Association for Research in Vision and Ophthalmology
Environmental Partners
Genetics Society of America
Inflammation Research Association
International Energy Agency Hydrogen Implementing
Agreement
International Society for Analytical Cytology
International Society for Biological and Environmental
Repositories
International Society for Interferon and Cytokine Research
Institute of Mathematical Statistics
Life Sciences Research Office
National Association of Orthopedic Technologists
North American Vascular Biology Organization
Pan American League of Associations for Rheumatology
Protein Data Bank
Ribonucleic Acid Society
Society for Free Radical Biology and Medicine
Society of Biological Inorganic Chemistry
Society of Chinese Bioscientists in America
Society for Leukocyte Biology
F A S E B
26
[ ]
F i n a n a c i a l R e p o r t 2 0 0 6[ ]
The Statement of Financial Position, Statement of Activities and Statement of Cash Flows
are reproduced on the following pages. These statements summarize the more detailed
financial statements audited by Tate and Tryon, P.C. A copy of the financial statements is
available upon request from the Office of the Chief Financial Officer and Deputy Executive
Director.
As required by Generally Accepted Accounting Principles (GAAP), the Federation reports
information regarding its financial position and activities according to three classes of net
assets: unrestricted, temporarily restricted and permanently restricted.
The majority of Federation activities and net assets are unrestricted and controlled by the
Federation Board.
The Federation has adopted Statement of Financial Accounting Standards (SFAS) 124
which requires debt and equity securities be reported at market value. The market value of
investments held by the Federation during the year increased $1,877,353 to a total of
$18,498,889. The market value of investments on December 31, 2005 totaled $16,621,536.
Statement of Financial Position
This statement presents the assets, liabilities and net assets of the Federation on December
31, 2006. The net assets, the difference between assets and liabilities, are $21,359,185. This
represents the accumulated net operating results of the organization during its 90+-year
history.
Investments of $18,498,889 are diversified in U.S.Treasury bills and notes, commercial
paper, commercial bonds, and common stock. The Federation has two major unrestricted
investment accounts—The Program Reserve and the Depreciation Reserve. The Program
Reserve provides financial security in the event of revenue failure or unanticipated cata-
strophic emergency, to serve as a hedge against the outstanding mortgage on the
Federation’s property and to support operations. The Depreciation Reserve provides for
capital improvements, renovations, and repairs or purchases of major equipment with a
unit price exceeding $5,000. In November 2006, the Federation purchased a swap against
interest rate risk associated with the variable rate loan from SunTrust bank. This swap effec-
tively fixes the interest rate on this debt for the remaining term of the bonds at 3.60%
27
The other significant asset of the Federation is the net investment of $17,434,000 in the build-
ings, grounds, furniture and equipment on the Beaumont campus, home to the Federation, its
constituent societies and other scientific and educational societies located on the campus.
Liabilities totaling $18,168,221 include amounts owed to vendors for products and services
received and the working capital credit line totaling $1,600,000, revenue received in 2006 but
applicable to programs to be conducted in 2007of $808,261, amounts owed to employees under
the deferred compensation plan of $431,459, and the building financing payable to SunTrust
bank for $12,725,000.
Statement of Activities
The Statement of Activities covers the 12 months for the calendar year ending December 31,
2006 and identifies the sources of revenue and expense. The financial plan adopted by the
Federation Board required the Board to set a rate for annual dues paid to the Federation by the
member societies. The dues rate for 2006 was $13 per society member with minimum dues of
$10,000 and a maximum of $125,000 per Society.
The accompanying statement shows total revenues of $18,383,243, including $613,568 of divi-
dends and interest and $1,013,548 of realized gains on investments and $51,728 of unrealized
gain on investments, and expenses of $17,928,056.This resulted in a net income of $1,520,463.
28
F i n a n a c i a l R e p o r t
$10,000,000
$8,000,000
$6,000,000
$4,000,000
$2,000,000
0Member
DuesCampus SupportServices
ProgramServices
Net ReserveEarnings
$10,000,000
$8,000,000
$6,000,000
$4,000,000
$2,000,000
0Core
Functions(OPA &
Leadership)
Campus SupportServices
ProgramServices
Net G&A
S O U R C E S O F R E V E N U E
A C T U A L E X P E N S E
2006 2005
S t a t e m e n t o f F i n a n c i a l Po s i t i o n
D e c e m b e r 3 1 , 2 0 0 6 2 0 0 5
ASSETS
Cash and cash equivalents - Note B $ 1,343,293 $ 1,349,089Investments - Notes B & C 18,064,476 16,201,985Accounts receivable
Trade receivables 365,140 409,841Government contracts and accounts 134,149 238,684Member societies and custodial grants - Note E 1,406,464 1,359,664Note receivable - Note J 150,000 100,000
Prepaid expenses 195,472 182,392 Interest rate cap contract - Note D 2,954 17,581Investment held to fund deferred compensation - Note H 431,459 401,970 Property and equipment
Land, building, and building improvements 23,696,125 23,480,159Furniture and equipment 3,017,556 2,983,654Less: accumulated depreciation (9,279,682) (8,590,845)
Net property and equipment 17,433,999 17,872,968
TOTAL ASSETS $ 39,527,406 $38,134,174
LIABILITIES AND NET ASSETS
LIABILITIES Accounts payable and accrued expenses $ 1,043,700 $ 1,060,021 Deferred revenue 808,261 854,195 Amounts held for member societies and custodial accounts - Note E 176,422 154,863 Amounts held for custodial funds from managed meetings - Note E 1,196,987 1,327,840 Deferred compensation - Note H 431,459 401,970Interest rate swap agreement - Note D 186,392 - Notes payable - economic development revenue bonds - Note I 12,725,000 13,000,000 Notes payable - line of credit - Note I 1,600,000 1,500,000
TOTAL LIABILITIES 18,168,221 18,298,889
NET ASSETS
Unrestricted 21,247,986 19,727,523Temporarily restricted - Note F 86,699 83,262Permanently restricted - Note G 24,500 24,500
TOTAL NET ASSETS 21,359,185 19,835,285
TOTAL LIABILITIES AND NET ASSETS $39,527,406 $38,134,174
29
F i n a n a c i a l R e p o r t
30
S t a t e m e n t o f A c t i v i t i e s
Ye a r E n d e d D e c e m b e r 3 1 , 2 0 0 6 2 0 0 5
UNRESTRICTED ACTIVITIES
REVENUE
Program services
Summer Research Conferences $ 4,907,069 $ 4,089,598
The FASEB Journal and Directory 2,263,987 2,200,361
MARC Program 1,581,769 1,445,299
Career Resources 126,127 136,960
Campus support services - Note E 7,517,582 6,844,601
Core functions 755,386 771,203
Investment income - Note C 613,568 526,557
General services 539,838 675,117
Net assets released from restrictions 77,917 38,948
Total unrestricted revenue 18,383,243 16,728,644
EXPENSE
Program services
Summer Research Conferences 4,314,598 3,650,958
MARC Program 1,581,775 1,445,308
The FASEB Journal and Directory 1,195,705 1,202,481
Career Resources 57,342 103,334
Campus support services - Note E 7,186,163 6,583,362
Core functions 1,207,532 1,333,544
Total program services 15,543,115 14,318,987
Supporting services
Investment expense 68,767 67,556
General and administrative 2,316,174 2,301,708
Total supporting services 2,384,941 2,369,264
Total expense 17,928,056 16,688,251
Change in unrestricted net assets before net gain on investments and change in interest swap valuation 455,187 40,393
Net gain on investments - Note C 1,251,668 158,682
Loss on fair value of interest swap agreement - Note D (186,392) -
Change in unrestricted net assets 1,520,463 199,075
TEMPORARILY RESTRICTED ACTIVITIES
Contributions 80,697 76,231
Investment income - Note C 657 498
Net assets released from restrictions (77,917) (38,948)
Change in temporarily restricted net assets 3,437 37,781
CHANGE IN NET ASSETS 1,523,900 236,856
Net assets, beginning of year 19,835,285 19,598,429
NET ASSETS, END OF YEAR $ 21,359,185 $ 19,835,285
F i n a n a c i a l R e p o r t
31
S t a t e m e n t o f C a s h F l o w s
Ye a r E n d e d D e c e m b e r 3 1 , 2 0 0 6 2 0 0 5
CASH FLOWS FROM OPERATING ACTIVITIESChange in net assests $ 1,523,900 $ 236,856Adjustments to reconcile change in net assests to net cash
provided by operating activities:Depreciation and amortization 735,485 683,370 Net gain on investments (1,251,806) (158,457)Loss on fair value of interest swap agreement 186,392 -Changes in assests and liabilities:
Accounts receivable 52,436 (125,235) Prepaid expenses (13,080) 86,354 Accounts payable and accrued expenses (16,321) 111,196Deferred revenue (45,934) 209,607 Amounts held for member societies and custodial accounts 21,559 3,381 Amounts held for custodial funds from managed accounts (130,853) 150,273
Total adjustments (462,122) 960,489Net cash provided by operating activities 1,061,778 1,197,345
CASH FLOWS FROM INVESTING ACTIVITIESNet purchases of investments (617,708) (130,647)Purchase of property and equipment (274,866) (702,483)Net cash used in investing activities (892,574 (833,130)
CASH FLOWS FROM FINANCING ACTIVITIESProceeds from the line of credit 100,000 350,000Principal payments on the economic development revenue bonds (275,000) -Net cash (used in) provided by financing activities (175,000) 350,000
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (5,796) 714,215Cash and cash equivalents, beginning of year 1,349,089 634,874
CASH AND CASH EQUIVALENTS, END OF YEAR $ 1,343,292 $ 1,349,089
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATIONCash paid during the year for interest $ 492,081 $ 350,973Cash paid during the year for income taxes $ 39,500 -
F i n a n a c i a l R e p o r t
32
M e m b e r S o c i e t i e s o f t h e F e d e r a t i o n
THE AMERICAN PHYSIOLOGICAL SOCIETY – APS
Founded: December 30, 1887
Founding Member of FASEB: 1912
Mission: The APS provides leadership in the life
sciences by promoting excellence and innovation in
physiological research and education and by provid-
ing information to the scientific community and to
the public.
President: Dale Benos, Dept. of Physiology and
Biophysics,University of Alabama at Birmingham
Executive Director: Martin Frank
Membership: 9,700
Publications:
American Journal of Physiology (AJP) Consolidated
AJP – Cell Physiology
AJP – Endocrinology and Metabolism
AJP – Gastrointestinal and Liver Physiology
AJP – Lung Cellular and Molecular Physiology
AJP – Heart and Circulatory Physiology
AJP – Regulatory, Integrative and Comparative
Physiology
AJP – Renal Physiology
Journal of Applied Physiology
Journal of Neurophysiology
Physiological Reviews
Physiological Genomics
Physiology
Advances in Physiology Education
The Physiologist
APS Journal Legacy Content
Website: www.the-aps.org
2006 Meetings:
Annual Meeting with Experimental Biology 2006,
San Francisco, California,April 1–5; APS Intersociety
Meeting: Comparative Physiology 2006: Integrating
Diversity,Virginia Beach, Virginia, October 8–11;
APS Conference: APS Physiological Genomics and
Proteomics of Lung Disease, Fort Lauderdale, Florida,
November 2–5
AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR
BIOLOGY – ASBMB
Founded: December 26, 1906
Founding Member of FASEB: 1912
Mission: Promoting understanding of the molecular
nature of life processes.
President: Heidi Hamm, Department of
Pharmacology,Vanderbilt University School of
Medicine, Nashville,Tennessee
Executive Director: Barbara A. Gordon
Membership: 11,700
Publications:
The Journal of Biological Chemistry
JBC Minireview Compendium
Molecular and Cellular Proteomics
Journal of Lipid Research
Biochemistry and Molecular Biology Education
ASBMB Today
Website: www.asbmb.org
2006 Meeting:
ASBMB, San Francisco, California,April 1–5
[ ]
32
33
AMERICAN SOCIETY FOR PHARMACOLOGY AND
EXPERIMENTAL THERAPEUTICS – ASPET
Founded: December 28, 1908
Founding Member of FASEB: 1912
Mission: The Society’s purpose is to promote the
advancement of the sciences of pharmacology and
experimental therapeutics and to facilitate the inter-
change of information among investigators who are
engaged in research in those fields by organizing
scientific meetings, publishing journals, and engaging
in other activities that advance the discipline.
President: Elaine Sanders-Bush,Vanderbilt
University, Nashville,Tennessee
Executive Director: Christine K. Carrico
Membership: 4,700
Publications:
The Pharmacologist
Journal of Pharmacology and Experimental
Therapeutics
Pharmacological Reviews
Molecular Pharmacology
Drug Metabolism and Disposition
Molecular Interventions
Website: www.aspet.org
2006 Meeting: Annual Meeting with Experimental
Biology 2006, San Francisco, California,April 1–5
AMERICAN SOCIETY FOR INVESTIGATIVE
PATHOLOGY-ASIP
Founded: December 1900
Member of FASEB: since1913
Mission: ASIP is a society of biomedical scientists
who investigate mechanisms of disease. Investigative
pathology is an integrative discipline that links the
presentation of disease in the whole organism to its
fundamental cellular and molecular mechanism. It
uses a variety of structural, functional, and genetic
techniques, and ultimately applies research findings
to the diagnosis and treatment of diseases. ASIP
advocates for the practice of investigative pathology
and fosters the professional career development and
education of its members.
President: Peter M. Howley, Department of Pathology,
Harvard Medical School, Boston, Massachusetts
Executive Director: Mark E. Sobel
Membership: 2,200
Publications:
The American Journal of Pathology
The Journal of Molecular Diagnostics
ASIP Pathways
Pathology: A Career in Medicine
Website: www.asip.org
2006 Meetings: Annual Meeting with Experimental
Biology 2006, San Francisco, California,April 1–5;
ISBER (Division of ASIP) Annual Meeting, Bethesda,
Maryland,April 30–May 2
M e m b e r S o c i e t i e s o f t h e F e d e r a t i o n
2
AMERICAN SOCIETY FOR NUTRITION – ASN
Founded: September 27, 1928
Member of FASEB: since 1940
Mission: To develop and extend knowledge of
nutrition of all species through fundamental, multi-
disciplinary, and clinical research; facilitate contact
among investigators in nutrition, medicine, and relat-
ed fields of interest; support the dissemination and
application of nutrition science to improve public
health and clinical practice worldwide; promote
graduate education and training of physicians in
nutrition; provide reliable nutrition information to
those who need it; and advocate for nutrition
research and its application to development and
implementation of policies and practices related to
nutrition.
President: Stephanie Atkinson, McMaster University
Faculty of Health Science, Hamilton, Ontario, Canada
Executive Director: John Courtney
Membership: 3,000
Publications:
American Journal of Clinical Nutrition
Journal of Nutrition
Nutrition Notes
Website: www.nutrition.org
2006 Meeting: Annual Meeting with Experimental
Biology 2006, San Francisco, California,April 1–5
THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS – AAI
Founded: June 19, 1913
Member of FASEB: since 1942
Mission: The AAI is an association of professionally
trained scientists dedicated to advancing the knowl-
edge of immunology and its related disciplines, foster-
ing the interchange of ideas and information among
investigators, and addressing the potential integration
of immunologic principles into clinical practice. AAI
serves its members by providing a center for the dis-
semination of information relevant to the field and its
practices such as educational and professional
opportunities, scientific meetings, membership
derived issues and opinions, and important social
and political issues.
President: Lewis L. Lanier, University of California,
San Francisco
Executive Director: M. Michele Hogan
Membership: 6,500
Publications:
The Journal of Immunology
AAI Newsletter
Website: www.aai.org
2006 Meeting: Immunology 2006, 93rd AAI Annual
Meeting, Boston, Massachusetts, May 12–16
34
M e m b e r S o c i e t i e s o f t h e F e d e r a t i o n M e m b e r S o c i e t i e s o f t h e F e d e r a t i o n
2
AMERICAN ASSOCIATION OF ANATOMISTS – AAA
Founded: September 17, 1888
Member of FASEB: since 1993
Mission: The purpose of the Association shall be the
advancement of anatomical sciences.
President: Kathy K. H. Svoboda, Baylor College of
Dentistry, Department of Biomedical Sciences,
Dallas,Texas
Executive Director: Andrea Pendleton
Membership: 1,800
Publications:
Developmental Dynamics
The Anatomical Record
The New Anatomist
AAA Newsletter
Website: www.anatomy.org
2006 Meeting: Annual Meeting with Experimental
Biology 2006, San Francisco, California,April 1–5
THE PROTEIN SOCIETY
Founded: February 11, 1986
Member of FASEB: since 1995
Mission: The Protein Society is the leading interna-
tional society devoted to furthering research and
development in protein science. The purpose of the
Society is to provide national and international
forums to facilitate communication, cooperation, and
collaboration with respect to all aspects of the study
of proteins. In support of these goals, the Society also
publishes Protein Science, the premier journal in the
field. Members have an opportunity to actively par-
ticipate in the emerging fields of protein including
proteomics, bioinformatics, structural biology, and
computational biology as they pertain to proteins at
the molecular and cellular level. The Protein Society
members represent academia, industry, government,
and nonprofit institutions from around the world.
President: Jeffery W. Kelly,The Scripps Research
Institute, La Jolla, California
Executive Officer: Cynthia A.Yablonski
Membership: 2,400
Publications:
Protein Science
Newsletter
Website: www.proteinsociety.org
2006 Meeting: 20th Symposium, San Diego,
California,August 5–9
35
M e m b e r S o c i e t i e s o f t h e F e d e r a t i o n
2
AMERICAN SOCIETY FOR BONE AND MINERAL RESEARCH
– ASBMR
Founded: 1977
Member of FASEB: since 1997
Mission: The ASBMR is a professional, scientific, and
medical society established to promote excellence in
bone and mineral research, to foster integration of
basic and clinical science, and to facilitate the trans-
lation of that science to health care and clinical
practice. Key objectives to achieve these goals
include the nurturing and development of future
generations of basic and clinical scientists, and the
dissemination of new knowledge in bone and miner-
al metabolism. The ASBMR is proactive in shaping
research and health policies based on scientific
advances in our field.
President: Steven R. Goldring, Hospital for Special
Surgery, New York, New York
Executive Director: Ann L. Elderkin
Membership: 3,900
Publications:
Journal of Bone and Mineral Research
Primer on the Metabolic Bone Diseases and Disorders
of Mineral Metabolism
ASBMRnews
Website: www.asbmr.org
2006 Meeting: ASBMR 28th Annual Meeting,
Philadelphia, Pennsylvania, September 15–19
AMERICAN SOCIETY FOR CLINICAL INVESTIGATION – ASCI
Founded: 1908
Member of FASEB: since 1998
Mission:The ASCI is an honor society of physician sci-
entists representing all disciplines of medical
science. Members are elected based upon the quality
and impact of their research, and their overall
contributions to the biomedical research community.
The Society seeks to particularly recognize physician-
scientists doing novel, creative, rigorous, and repro-
ducible research which is based on a solid founda-
tion of science and likely to stand the test of time.
The ASCI is organized and operated exclusively for
educational and scientific purposes. In furthering
these aims, the society convenes an annual
meeting and publishes the Journal of Clinical
Investigation, both of which highlight high-impact
work from a broad range of disciplines.
President: Eric R. Fearon, University of Michigan
Medical School,Ann Arbor, Michigan
Executive Director: John B. Hawley
Membership: 2,900
Publication:
The Journal of Clinical Investigation
Website: www.asci-jci.org
2006 Meeting:
Chicago, Illinois,April 28–30
36
M e m b e r S o c i e t i e s o f t h e F e d e r a t i o n
2
THE ENDOCRINE SOCIETY – TES
Founded: 1916
Member of FASEB: since 1999
Mission: Since its inception in 1916,The Endocrine
Society has worked to promote excellence in hor-
mone research and care of patients with endocrine
disease. With over 12,600 members from over 80
countries,The Endocrine Society is the world’s largest
and most active organization devoted to the
research, study, and clinical practice of endocrinolo-
gy. Together, the scientists, educators, clinicians, prac-
ticing MDs, nurses, and students who make up the
organization’s membership represent all basic,
applied, and clinical interests in endocrinology.
President: Leonard Wartofsky,Washington Hospital
Center,Washington, DC
Executive Director: Scott Hunt
Membership: 13,000
Publications:
Endocrinology
The Journal of Clinical Endocrinology and Metabolism
Endocrine Reviews
Molecular Endocrinology
Endocrine News
Website: www.endo-society.org
2006 Meetings: ENDO ‘06 (88th Annual Meeting),
Boston, Massachusetts, June 24–27; Clinical
Endocrinology Update, San Francisco, California,
October 6–9
THE AMERICAN SOCIETY OF HUMAN GENETICS – ASHG
Founded: 1948
Member of FASEB: since 1999
Mission: The American Society of Human Genetics
serves research scientists, health professionals and the
public by enabling its members to: share research
results at annual meetings and publish in the
American Journal of Human Genetics, advance genetic
research by advocating for research support, enhance
genetics education by preparing future
professionals and informing the public, promote
genetic services and support responsible social and
scientific policies.
President: Stephen Warren, Emory University,
Atlanta, Georgia
Executive Vice President: Joann Boughman
Executive Director: Elaine Strass
Membership: 7,000
Publications:
The American Journal of Human Genetics
Guide to North American Graduate and Postgraduate
Training Programs in Human Genetics
Solving the Puzzle–Careers in Genetics
Website: www.ashg.org
2006 Meeting: New Orleans, Louisiana, October 9–13
37
M e m b e r S o c i e t i e s o f t h e F e d e r a t i o n
38
SOCIETY FOR DEVELOPMENTAL BIOLOGY – SDB
Founded: 1939
Associate member of FASEB: 1996
Full member of FASEB: since 2001
Mission: The purpose of the Society is to further the
study of development in all organisms and at all lev-
els, and to represent and promote communication
among students of development.
President: Elliot Meyerowitz, Division of Biology,
California Institute of Technology, Pasadena,
California
Executive Director: Ida Chow
Membership: 2,100
Publication:
Developmental Biology
Website: www.sdbonline.org
2006 Meeting: 65th SDB Annual Meeting, University
of Michigan,Ann Arbor, Michigan, June 17–21
AMERICAN PEPTIDE SOCIETY – APEPS
Founded: 1990
Associate member of FASEB: since 1996
Mission: The purposes of the Society are to advance
and promote the knowledge of the chemistry and
biology of peptides and proteins.
President: Jane V.Aldrich, Department of Medicinal
Chemistry, University of Kansas, Lawrence, Kansas
Membership: 500
Publication:
Biopolymers (Peptide Science)
Website: www.ampepsoc.org
ASSOCIATION OF BIOMOLECULAR RESOURCE FACILITIES –
ABRF
Founded: 1988
Associate member of FASEB: since 1997
Mission: The Association of Biomolecular Resource
Facilities is an international society dedicated to
advancing core and research biotechnology labora-
tories through research,communication,and educa-
tion.
President: Jay W. Fox, University of Virginia,
Charlottesville,Virginia
Membership: 700
Publication:
Journal of Biomolecular Techniques
Website: www.abrf.org
2006 Meeting: Long Beach, California,
February 11–14
SOCIETY FOR THE STUDY OF REPRODUCTION – SSR
Founded: 1967
Associate member of FASEB: since 1998
Mission: The mission of the Society is to promote
the study of reproduction by fostering interdiscipli-
nary communication among scientists, holding con-
ferences, and publishing meritorious studies.
President: William W.Thatcher, Dept. of Animal
Sciences, University of Florida, Gainesville, Florida
Executive Officer: Judith Jansen
Membership: 2,800
Publications:
Biology of Reproduction
Biology of Reproduction Online
Biology of Reproduction Monograph Series 1; Equine
Reproduction VI
SSR Newsletter
Website: www.ssr.org
2006 Meeting: 39th Annual Meeting, Omaha,
Nebraska, July 29–August 1
M e m b e r S o c i e t i e s o f t h e F e d e r a t i o n
TERATOLOGY SOCIETY
Founded: 1961
Associate member of FASEB: since 1998
Mission: The objective of the Teratology Society is to
promote research and the exchange of ideas and
research results that reveal the causes, improve the
diagnosis and treatment, and prevent the occurrence
of abnormal development and birth defects; to com-
municate that information to physicians, public
health officials, concerned health advocacy and lay
groups and other interested parties that promote the
elimination of birth defects when possible and ame-
lioration of them when they occur; and to provide
education and training on the causes, mechanisms,
treatment and prevention of birth defects.
President: Melissa Sherman Tassinari, DABT,
Pfizer, Inc, New London, Connecticut
Vice President: Elaine M. Faustman, University of
Washington, Seattle,Washington
Executive Director: Tonia Masson
Membership: 700
Publications:
Birth Defects Research,Part A,B,and C
Newsletter
Website: www.teratology.org
2006 Meeting: 46th Annual Meeting,Tucson,
Arizona, June 24–29
SOCIETY FOR GYNECOLOGIC INVESTIGATION – SGI
Founded: 1953
Associate Member of FASEB: since 2000
Mission: The mission of the Society for Gynecologic
Investigation is to establish the scientific basis for
gynecology, obstetrics, and related disciplines by pro-
viding and promoting: 1. Leadership and excellence in
research 2. International forums for scientific
exchange 3. Mentoring, career development, and
education 4.Advocacy for research in women’s health
and reproductive science and 5. Collaboration with
academia, government, industry, and professional
organizations.
President: Gerson Weiss, Dept. OB/GYN, UMDNJ –
New Jersey Medical School, Newark, New Jersey
Executive Director: Ava A.Tayman
Membership: 1,000
Publication:
Journal of the Society for Gynecologic Investigation
Website: http://sgionline.org
2006 Meeting: Toronto, Canada, March 22–25
M e m b e r S o c i e t i e s o f t h e F e d e r a t i o n
39
ENVIRONMENTAL MUTAGEN SOCIETY – EMS
Founded: 1969
Associate member of FASEB: since 2001
Mission: The Environmental Mutagen Society (EMS)
is the primary scientific society fostering research on
the basic mechanisms of mutagenesis as well as on
the application of this knowledge in the field of
genetic toxicology. EMS has seven core scientific
content areas. These are: 1. Exposure, detection and
metabolism of DNA damaging agents, 2. Responses to
DNA damage (DNA repair and recombination,
changes in gene expression, cell cycle effects), 3.
Mutational mechanisms (spontaneous and exposure
related), 4. DNA technologies, 5. Molecular epidemiol-
ogy, 6. Human health effects (developmental, cancer,
aging, genetic disease), 7.Applications: testing, regula-
tory issues and risk assessment.
President: Martina L.Veigl, Case Western Reserve
University, Cancer Center Lab, Cleveland, Ohio
President-Elect: Andrew J.Wyrobek, Lawrence
Berkeley National Laboratory, Department of
Radiation Biosciences, Berkley, California
Executive Director: Tonia Masson
Membership: 700
Publications:
Environmental and Molecular Mutagenesis
Newsletter
Website: www.ems-us.org
2006 Meeting: 37th Annual Meeting of the
Environmental Mutagen Society,Vancouver, Canada,
September 16–20
INTERNATIONAL SOCIETY FOR COMPUTATIONAL
BIOLOGY – ISCB
Founded: 1996
Associate member of FASEB: since 2003
Mission: The International Society for Computational
Biology is a scholarly society dedicated to advancing
the scientific understanding of living systems through
computation. The ISCB communicates the signifi-
cance of our science to the larger scientific communi-
ty, governments, and the public at large. The ISCB
serves a global membership by impacting govern-
ment and scientific policies, providing high quality
publications and meetings, and through distribution
of valuable information about training, education,
employment and relevant news from related fields.
President: Michael Gribskov, Dept. of Biological
Sciences, Purdue University,West Lafayette, Indiana
Executive Officer: BJ Morrison McKay
Membership: 1,800
Website: www.iscb.org
2006 Meeting:
14th Annual Intelligent Systems for Molecular Biology,
Fortaleza, Brazil,August 6–11; 4th Annual Rocky
Mountain Regional Bioinformatics Conference,
Snowmass, Colorado, December 1–3
M e m b e r S o c i e t i e s o f t h e F e d e r a t i o n
40
AMERICAN ASSOCIATION OF PHYSICIANS – AAP
Founded: 1885
Member of FASEB: since 2005
Mission: The goals of its members include the pur-
suit of medical knowledge, and the advancement
through experimentation and discovery of basic and
clinical science and their application to clinical med-
icine. Each year, 55 individuals having attained excel-
lence in achieving these goals, are recognized by
nomination for membership by the Council of the
Association. Their election gives them the opportuni-
ty to share their scientific discoveries and contribu-
tions with their colleagues at the annual meeting.
President: Jerrold Olefsky, University of California,
San Diego, La Jolla, California
Membership: 1,145
2006 Meeting: Chicago, Illinois,April 28–30
AMERICAN COLLEGE OF SPORTS MEDICINE – ACSM
Founded: 1954
Member of FASEB: since 2005
Mission: The American College of Sports Medicine
promotes and integrates scientific research, educa-
tion, and practical applications of sports medicine
and exercise science to maintain and enhance physi-
cal performance, fitness, health, and quality of life.
President: J. Larry Durstine, Department of Exercise
Science, University of South Carolina, Columbia,
South Carolina
Executive Vice President: James R.Whitehead
Membership: 20,000
Publications:
Medicine & Science in Sports & Exercise
Exercise and Sport Science Reviews
Sports Medicine Bulletin
ACSM’s Health and Fitness Journal
Current Sports Medicine Reports
ACSM’s Certified e-News
ACSM FIT Society Page
Website: www.acsm.org
2006 Meetings:
53rd Annual Meeting, Denver, Colorado,
May 23–June 3
ACSM’s Health & Fitness Summit & Exposition
Orlando, Florida, April 11–14
M e m b e r S o c i e t i e s o f t h e F e d e r a t i o n
41
9650 Rockville Pike, Bethesda, MD 20814
Phone 301.634.7000 • Fax 301.634.7001
www.faseb.org • [email protected]